mutations

GENETIC2 trials

Sponsors

Beijing Institute of Hepatology, Hellenic Cooperative Oncology Group

Conditions

Germline Mutation AbnormalityHepatitis BHereditary CancerPancreatic CancerPredisposition, Genetic

Unknown Phase

Clinical trial of hepatitis B drug resistance research

RecruitingChiCTR1800020385

Beijing Institute of HepatologyHepatitis B

Start: 2018-01-01Updated: 2019-01-14

Germline Mutations in Pancreatic Adenocarcinoma

CompletedNCT03982446

Hellenic Cooperative Oncology GroupGermline Mutation Abnormality, Hereditary Cancer, Pancreatic Cancer +1

Start: 2016-03-01End: 2020-01-03Updated: 2021-02-12

Related Papers

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma

Cancers2021-01-0817 citations